[email protected] +91 9789129171
ICBSO · Registering as Listener

International Conference on Biomedical Sciences and Oncology

11 - 12 Feb 2027 Tartu, Estonia Standard / Physical Participation
Listener Registration
$125
virtual · $155 in person
Registration Benefits:
Official invitation letterIssued automatically after registration
Certificate & digital materialsGet certificate, slides and resource materials
Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.


Coupon code

Have a code? Apply it here — the discount updates the total immediately.


Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceICBSO
ModeStandard / Physical
ParticipationListener
Registration fee$155.00
Bank charges (5.8%)$8.99
Total payable$163.99
Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

+91 9789129171

Benefits of Registering as Listener

Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
• Conference Session Tracks •
SDGs
SDG-Aligned Research Themes

ICBSO conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 - Good Health and Well-being SDG 4 - Quality Education SDG 9 - Industry, Innovation and Infrastructure SDG 16 - Peace, Justice and Strong Institutions
01 Innovative Approaches in Tumor Localization +
This track will explore advanced techniques and methodologies for the precise localization of human tumors. Emphasis will be placed on imaging technologies and their integration with clinical practices.
02 Molecular Mechanisms in Cancer Biology +
This session will focus on the biochemical and molecular pathways that drive cancer progression. Discussions will include the role of signaling pathways and their implications for targeted therapies.
03 Translational Research in Oncology +
This track aims to bridge the gap between laboratory research and clinical application in oncology. It will highlight successful case studies and innovative strategies in translational research.
04 Clinical Trials and Drug Development +
This session will cover the latest advancements in clinical trial design and drug discovery processes. Participants will discuss challenges and opportunities in bringing new oncology therapies to market.
05 Biostatistics in Biomedical Research +
This track will delve into the application of statistical methods in biomedical research, particularly in oncology. It will address the importance of biostatistics in data analysis and interpretation.
06 Biotechnology Innovations in Cancer Treatment +
This session will showcase cutting-edge biotechnological advancements that are transforming cancer treatment. Topics will include gene therapy, immunotherapy, and personalized medicine.
07 Functional Genomics in Cancer Research +
This track will explore the role of functional genomics in understanding cancer biology. Discussions will focus on how genomic data can inform therapeutic strategies and patient outcomes.
08 Pediatric Oncology: Challenges and Advances +
This session will address the unique challenges faced in the field of pediatric oncology. It will highlight recent advancements in treatment protocols and supportive care for young patients.
09 Gynaecological Oncology: Current Trends +
This track will focus on the latest research and clinical practices in gynaecological oncology. Emphasis will be placed on early detection, treatment modalities, and patient management.
10 Clinical Pathophysiology in Oncology +
This session will examine the clinical pathophysiological aspects of cancer. Discussions will include the interplay between cancer biology and clinical manifestations.
11 Ethics and Policy in Biomedical Research +
This track will address the ethical considerations and policy implications surrounding biomedical research in oncology. It will foster discussions on responsible research practices and patient rights.